| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/09/2010 | CA2403670C Multiparticulate drug form comprising at least two differently coated pellet forms |
| 02/09/2010 | CA2378431C Peptides that lower blood glucose levels |
| 02/09/2010 | CA2375201C Crystal of (r)-lansoprazole |
| 02/09/2010 | CA2293806C Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010014836A2 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | WO2010014651A1 Pharmacogenetic markers for susceptibility to drug-induced pancreatic toxicity |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor |
| 02/04/2010 | WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2010 | WO2010012611A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2010012244A1 Small rna interference target site sequences of hepatitis b virus and small interference rnas and the compositions and uses thereof |
| 02/04/2010 | WO2009103788A9 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 02/04/2010 | US20100029757 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases |
| 02/04/2010 | US20100029755 P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029697 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 02/04/2010 | US20100029692 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 02/04/2010 | US20100029672 Method of treating liver disease |
| 02/04/2010 | US20100029641 Aryl sulfamide derivatives and methods of their use |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029622 Microemulsions |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100028970 Medium for the Production of Tiacumicin B |
| 02/04/2010 | US20100028455 Nutritional supplement |
| 02/04/2010 | US20100028449 Fermented milk product and use thereof |
| 02/04/2010 | US20100028422 Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease |
| 02/04/2010 | US20100028405 Matrix, cell implantation and method for their production and use |
| 02/04/2010 | US20100028350 Preventing il-2 mediated inflammation in epithelial cells |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028316 Moderating the effect of endotoxins |
| 02/04/2010 | US20100028315 Dried and/or microencapsulated saccharomyces cerevisiae cells with a high content of (s)-(+)-s-adenosyl-l-methionine, process for their preparation, and compositons containing said cells |
| 02/04/2010 | US20100028274 Oral disinfectant, and food additive comprising the disinfectant |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | CA2732323A1 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2149549A1 Pharmaceutical composition for prevention or treatment of hepatitis |
| 02/03/2010 | EP2149382A1 Dentinogenesis promoter and dentinogenic pulp-capping material |
| 02/03/2010 | EP2149379A1 Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148867A1 Deuterated morpholinyl compounds |
| 02/03/2010 | EP2148693A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/03/2010 | CN100586297C Composition against periodontal bacteria |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2436752C Bifidobacteria and preparations containing them |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 01/28/2010 | WO2010011879A2 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | WO2010011599A2 Pimethixene derivatives for promoting bone growth |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2010011347A2 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010010172A2 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | WO2010010056A1 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/28/2010 | WO2010009589A1 Use of hydrochloric acid for the manufacture of a medicament for treatment of gastritis, enteritis and angiitis |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022748 Prophylactic agent for renal failure |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022631 Treatment of hepatic encephalopathy and liver cirrhosis |
| 01/28/2010 | US20100022619 Compositions and their uses directed to ptpr alpha |
| 01/28/2010 | US20100022581 Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |
| 01/28/2010 | US20100022571 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 01/28/2010 | US20100022519 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 01/28/2010 | US20100022498 Steroids as agonists for fxr |
| 01/28/2010 | US20100022484 4-Chromenonyl-1,4-dihydropyridines and their use |
| 01/28/2010 | US20100021568 Anti-Obesity Product And Its Method Of Preparation |
| 01/28/2010 | US20100021554 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin |
| 01/28/2010 | US20100021536 Enhanced-diffusion capsule |
| 01/28/2010 | US20100021505 Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021481 Conjugates of an anti-tnf-alpha antibody |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021455 Methods for diagnosis and treatment of crohn's disease |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | US20100021386 Treatment, prevention,and reversal of alcohol-induced liver disease |
| 01/28/2010 | CA2737146A1 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | CA2732228A1 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2731500A1 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | CA2731254A1 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/27/2010 | EP2147922A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/27/2010 | EP2147918A1 Process for the preparation of S-omeprazole magnesium in a stable form |